Clinical Drug Experience Knowledgebase

Acute Coronary Syndrome (Phase 3)

Acute Kidney Injury (Phase 3)

Antiphospholipid Syndrome (Phase 4)

Apnea (Phase 1)

Arachnodactyly (Phase 2)

Atherosclerosis (Phase 3)

Atrial Fibrillation (Phase 4)

Brain Injuries (Phase 3)

Brain Injuries, Traumatic (Phase 3)

Cardiomyopathies (Phase 3)

Cardiomyopathy, Hypertrophic (Phase 3)

Cardiovascular Diseases (Phase 4)

Cerebral Hemorrhage (Phase 2)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 1 (Phase 3)

Embolism (Phase 3)

Glucose Intolerance (Phase 3)

Glucose Metabolism Disorders (Phase 3)

Heart Arrest (Phase 3)

Heart Diseases (Phase 4)

Heart Failure (Phase 4)

Heart Valve Diseases (Phase 3)

Hematoma (Phase 3)

Hemorrhage (Phase 2)

Hypertension (Phase 2)

Hypertrophy (Phase 3)

Infarction (Phase 3)

Lupus Erythematosus, Systemic (Phase 4)

Marfan Syndrome (Phase 2)

Mental Disorders (Phase 4)

Metabolic Diseases (Phase 3)

Metabolic Syndrome (Phase 3)

Myocardial Infarction (Phase 3)

Myocardial Ischemia (Phase 4)

Osteoporosis (Phase 3)

Out-of-Hospital Cardiac Arrest (Phase 3)

Peripheral Arterial Disease (Phase 3)

Peripheral Vascular Diseases (Phase 3)

Pulmonary Embolism (Phase 3)

Renal Insufficiency (Phase 3)

Sleep Apnea, Obstructive (Phase 1)

Sleep Apnea Syndromes (Phase 1)

Syndrome (Phase 4)

Tachycardia (Phase 4)

Tachycardia, Ventricular (Phase 4)

Thromboembolism (Phase 3)

Thrombosis (Phase 3)

Vascular Diseases (Phase 3)

Venous Thromboembolism (Phase 3)

Venous Thrombosis (Phase 3)

Ventricular Fibrillation (Phase 3)

Wounds and Injuries (Phase 3)